Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Regulatory  ·  Weekly Digest - 24 October to 30 October 2026
China’s NMPA accepted the application for Disitamab vedotin plus subcutaneous Toripalimab for HER2-expressing Urothelial carcinoma

Weekly Digest – October 2026 Weekly Digest – October 2026 22 October 2026: BioNTech and Gilead partner to evaluate Pumitamig plus Trodelvy in 1L TNBC BioNTech announced a clinical trial collaboration and supply agreement with Gilead Sciences to evaluate pumitamig […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 24 October to 30 October 2026
VitsGen Therapeutics receives FDA ODD for FAP-Targeted Radiopharmaceutical 177Lu-FAP-VG11

Weekly Digest – October 2026 Weekly Digest – October 2026 26 October 2026: VitsGen Therapeutics receives FDA ODD for FAP-Targeted Radiopharmaceutical 177Lu-FAP-VG11 VitsGen Therapeutics announced that the U.S. FDA has granted Orphan Drug Designation to 177Lu-FAP-VG11 for the treatment of […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 24 October to 30 October 2026
AimedBio and Boehringer Ingelheim initiate Phase 1 study of ADC BI 4060107

Weekly Digest – October 2026 Weekly Digest – October 2026 27 October 2026: AimedBio and Boehringer Ingelheim initiate Phase 1 study of ADC BI 4060107 AimedBio and Boehringer Ingelheim announced that the first patient has been dosed in the phase […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 24 October to 30 October 2026
Xilio Therapeutics dosed the first patient in the Phase 1/2 trial of XTX501 for metastatic NSCLC

Weekly Digest – October 2026 Weekly Digest – October 2026 26 October 2026: Xilio Therapeutics dosed the first patient in the Phase 1/2 trial of XTX501 for metastatic NSCLC Xilio Therapeutics has dosed the first patient in a phase 1/2 […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 17 October to 23 October 2026
Enhertu approved in China for previously treated patients with HER2+ metastatic Solid tumors

Weekly Digest – October 2026 Weekly Digest – October 2026 22 October 2026: Enhertu approved in China for previously treated patients with HER2+ metastatic Solid tumors Daiichi Sankyo and AstraZeneca announced that Enhertu has received conditional approval in China as […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 17 October to 23 October 2026
European Commission expands PADCEV + Keytruda approval to resectable MIBC, regardless of cisplatin eligibility

Weekly Digest – October 2026 Weekly Digest – October 2026 23 October 2026: European Commission expands PADCEV + Keytruda approval to resectable MIBC, regardless of cisplatin eligibility Astellas announced that the European Commission has expanded the approval of PADCEV plus […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 17 October to 23 October 2026
Samsung Bioepis receives FDA FTD for SBE303 for the treatment of Urothelial cancer

Weekly Digest – October 2026 Weekly Digest – October 2026 21 October 2026: Samsung Bioepis receives FDA FTD for SBE303 for the treatment of Urothelial cancer Samsung Bioepis announced that the U.S. FDA has granted Fast Track Designation to SBE303, […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 17 October to 23 October 2026
Medicovestor announces FDA FTD for MC001, a FIC ADC for Pancreatic cancer

Weekly Digest – October 2026 Weekly Digest – October 2026 20 October 2026: Medicovestor announces FDA FTD for MC001, a first-in-class ADC for Pancreatic cancer Medicovestor announced that the U.S. FDA has granted Fast Track Designation to MC001, its investigational […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 17 October to 23 October 2026
Hansoh Pharma announces strategic collaboration and license agreement with Roche to advance novel ADC portfolio

Weekly Digest – October 2026 Weekly Digest – October 2026 19 October 2026: Hansoh Pharma announces strategic collaboration and license agreement with Roche to advance novel ADC portfolio Hansoh Pharma announced a strategic collaboration and licensing agreement with Roche to […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 17 October to 23 October 2026
BioNTech and Gilead partner to evaluate Pumitamig plus Trodelvy in 1L TNBC

Weekly Digest – October 2026 Weekly Digest – October 2026 22 October 2026: BioNTech and Gilead partner to evaluate Pumitamig plus Trodelvy in 1L TNBC BioNTech announced a clinical trial collaboration and supply agreement with Gilead Sciences to evaluate pumitamig […]

by Sandhya Ramalingam

Continue Reading
‹ Previous1234567Next ›Last »
Page 3 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id